Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 730.78M |
| Enterprise value | 612.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.97 |
| Price/book (mrq) | 31.69 |
| Enterprise value/revenue | 4.48 |
| Enterprise value/EBITDA | -6.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.01 |
| 52-week change 3 | -8.48% |
| S&P500 52-week change 3 | -13.66% |
| 52-week high 3 | 11.69 |
| 52-week low 3 | 2.50 |
| 50-day moving average 3 | 5.41 |
| 200-day moving average 3 | 5.89 |
Share statistics
| Avg vol (3-month) 3 | 1.12M |
| Avg vol (10-day) 3 | 1.59M |
| Shares outstanding 5 | 124.07M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 92.53M |
| % held by insiders 1 | 6.69% |
| % held by institutions 1 | 81.64% |
| Shares short (30 Aug 2022) 4 | 3.42M |
| Short ratio (30 Aug 2022) 4 | 4.22 |
| Short % of float (30 Aug 2022) 4 | 3.88% |
| Short % of shares outstanding (30 Aug 2022) 4 | 2.75% |
| Shares short (prior month 28 July 2022) 4 | 3.72M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | -75.48% |
| Operating margin (ttm) | -73.25% |
Management effectiveness
| Return on assets (ttm) | -23.05% |
| Return on equity (ttm) | -166.19% |
Income statement
| Revenue (ttm) | 136.66M |
| Revenue per share (ttm) | 1.49 |
| Quarterly revenue growth (yoy) | -76.90% |
| Gross profit (ttm) | 3.04M |
| EBITDA | -93.8M |
| Net income avi to common (ttm) | -103.14M |
| Diluted EPS (ttm) | -0.94 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 195.8M |
| Total cash per share (mrq) | 1.58 |
| Total debt (mrq) | 77.21M |
| Total debt/equity (mrq) | 334.83 |
| Current ratio (mrq) | 2.35 |
| Book value per share (mrq) | 0.25 |
Cash flow statement
| Operating cash flow (ttm) | -40.46M |
| Levered free cash flow (ttm) | -11.54M |
© 2022 Yahoo. All rights reserved.
